Patterns of care among patients for advanced renal cell carcinoma

What is it about?

At present, the metastatic renal cell carcinoma therapeutic landscape in industrialized countries resembles, to a certain extent, the one shown therein: a growing number of metastatic renal cell carcinoma patients are receiving several lines of treatments sequentially, and this abundance of options has undoubtedly improved their survival.

Featured Image

Why is it important?

What in recent years has happened in Italy is definitely more difficult to understand; denying highly active treatments to cancer patients just because the Italian Agency for Drugs “fights” pharmaceutical companies over drug prices is really hard to accept. This is just an ultimately useless way to save money, without any serious attempt to prioritize expenses by evaluating how much expense is worthwhile for a given clinical benefit.

Perspectives